Projectes

IrsiCaixa compta amb un centenar de projectes de recerca nacionals i internacionals actius cada any, finançats tant per entitats públiques com privades.

Paraules clau

Grup de recerca

Investigador/a

Des del

Fins el

New genetic engineering tools for the treatment of AIDS "STOP-AIDS"

Estatus del projecte

Vigent

Inici/Fi

2016

/

2019

Investigador/a principal

Javier Martínez-Picado

Entitats participants

IrsiCaixa AIDS Research Institute and 3 other Spanish centers.

Entitat finançadora

Spanish Ministry of Economy and Competitiveness, Secretariat of state for research, development and innovation; Retos-Colaboración RTC-2016-5324-1
Nuevas estrategias terapéuticas basadas en inhibidores de tirosina kinasas para la eliminación del reservorio latente del VIH-1 (TKICure)

Estatus del projecte

Vigent

Inici/Fi

2020

/

2023

Investigador/a principal

Javier Martínez-Picado

Entitats participants

IrsiCaixa AIDS Research Institute, Instituto de Salud Carlos III

Línia estratègica

Teràpies i vacunes

Entitat finançadora

Spanish Ministry of Science and Innovation
DURVAST: A phase II exploratory study of durvalumab (MEDI4736) in HIV-1 patients with advanced solid tumors

Estatus del projecte

Vigent

Inici/Fi

2017

/

2019

Investigador/a principal

Javier Martínez-Picado

Entitats participants

Spanish Lung Cancer Cooperative Group & IrsiCaixa AIDS Research Institute.

Entitat finançadora

AstraZeneca
Non-invasive viral reservoir characterization in Lymph Nodes through Fine Needle Biopsies in patients with distinct HIV progression profiles

Estatus del projecte

Vigent

Inici/Fi

2017

/

2019

Investigador/a principal

Javier Martínez-Picado

Entitats participants

IrsiCaixa AIDS Research Institute

Entitat finançadora

Gilead Sciences
Glicoingeniería de nanovehículos para eliminar los reservorios virales; saf2017-91767-exp

Estatus del projecte

Vigent

Inici/Fi

Investigador/a principal

Nuria Izquierdo Useros

Entitats participants

Irsicaixa, ICN2, UPV-CSIC

Entitat finançadora

MINECO
Allogeneic stem cell transplantation in HIV-1 infected individuals and 1st ITATI strategy

Estatus del projecte

Vigent

Inici/Fi

2018

/

2020

Investigador/a principal

Javier Martínez-Picado

Entitats participants

Foundation for AIDS Research amFAR (ARCHE program); ref 109858-64-RSRL
Treatment with immunological checkpoint inhibitors of HIV-infected subjects with cancer

Estatus del projecte

Vigent

Inici/Fi

2018

/

2023

Investigador/a principal

Javier Martínez-Picado

Entitat finançadora

Merck Sharp & Dohme de España, SA (MSD); ref IISP 57699
Characterisation of single molecule dynamics within HIV-1 reservoirs as a target for interference with virus persistence and immune evasion

Estatus del projecte

Vigent

Inici/Fi

2019

/

2020

Investigador/a principal

Javier Martínez-Picado

Jakub Chojnacki

Entitat finançadora

European Comission (H2020)
SIGTECH - New technologies mimicking virus-cell interaction to fight infectious diseases

Estatus del projecte

Vigent

Inici/Fi

2018

/

2023

Investigador/a principal

Javier Martínez-Picado

Nuria Izquierdo Useros

Entitat finançadora

Grifols
VIROCURE - Cutting edge strategies on HIV cure

Estatus del projecte

Vigent

Inici/Fi

2018

/

2023

Investigador/a principal

Javier Martínez-Picado

Entitat finançadora

Grifols